3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
17
Stomach Neoplasms
8
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Rectal Neoplasms
5
Neoplasm Metastasis
4
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Nasopharyngeal Carcinoma
3
Esophageal Neoplasms
3
Uterine Cervical Neoplasms
2
Solid Tumor
2
Recurrence
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Endometrial Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Spinocerebellar Degenerations
1
Small Cell Lung Carcinoma
1
Resectable NSCLC
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Metastatic Gastroesophageal Junction Adenocarcinoma
1
Meningeal Carcinomatosis
1
MSI-H
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Interventions
Gemcitabine
32
Cisplatin
31
durvalumab
15
pembrolizumab
14
Fluorouracil
13
Oxaliplatin
12
Leucovorin
12
Capecitabine
10
Bevacizumab
8
lenvatinib
7
Nivolumab
7
zanidatamab
4
Trastuzumab
4
S 1 (combination)
4
Paclitaxel
4
Liquid Biopsy
4
Irinotecan
4
Carboplatin
4
Albumin-Bound Paclitaxel
4
tremelimumab
3
tislelizumab
3
irinotecan sucrosofate
3
Injections
3
Folfox protocol
3
130-nm albumin-bound paclitaxel
3
toripalimab
2
pertuzumab
2
niraparib
2
ivosidenib
2
envafolimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
sintilimab
×
1 year
×
Clear all
No trials found.